TUB-030
- Generic Name
- TUB-030
First in Human Study of TUB-030 in Patients with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorsHNSCCSCLCNSCLCTNBC - Triple-Negative Breast CancerCRC
- Interventions
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Tubulis GmbH
- Target Recruit Count
- 130
- Registration Number
- NCT06657222
- Locations
- 🇺🇸
NEXT Oncology Austin, Austin, Texas, United States
🇺🇸NEXT Oncology - Dallas, Irving, Texas, United States
🇺🇸NEXT Oncology - San Antonio, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath